Landscape Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Landscape Capital Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-650	Closed	-$203K	–	655
2019 Q2	$203K	Buy	+650	New	+$195K	0.02%	598
2018 Q4	–	Sell	-5,844	Closed	-$1.83M	–	860
2018 Q3	$1.83M	Buy	+5,844	New	+$1.81M	0.14%	138
2016 Q4	–	Sell	-1,933	Closed	-$317K	–	554
2016 Q3	$317K	Buy	+1,933	New	+$293K	0.04%	303
2015 Q2	–	Sell	-3,000	Closed	-$406K	–	693
2015 Q1	$406K	Buy	+3,000	New	+$372K	0.11%	277

Other funds holding BIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Landscape Capital Management's BIO Position: Q3 2019 in Review

Landscape Capital Management sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2019, closing a stake of 650 shares — an estimated $203K sold.

Landscape Capital Management first reported a position in BIO in Q1 2015 and held it in 4 quarters. The position peaked at $1.83M in Q3 2018. 354 funds tracked by Wall St. Rank hold BIO as of Q3 2019.

Landscape Capital Management reported no remaining Bio-Rad Laboratories Class A position as of Q3 2019 after selling out during the quarter.
Landscape Capital Management sold 650 Bio-Rad Laboratories Class A shares in Q3 2019, an estimated $203K.
Landscape Capital Management first reported a position in Bio-Rad Laboratories Class A in Q1 2015 and held it in 4 quarters.
Landscape Capital Management's Bio-Rad Laboratories Class A position peaked at $1.83M in Q3 2018.
354 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2019.

Based on Landscape Capital Management's 13F filing for Q3 2019, filed 12 Nov 2019.